Stem cell-based Parternship Resource for Investigating Human Diseases and Training (SPRINT)

  • Post author:
  • Post category:

Use of stem cells in human disease modeling has reached a broader scientific audience of underserved, marginalized communities. Researchers/scholars have comprehensive training in iPSC generation, genetic modification, and differentiation techniques…

Continue ReadingStem cell-based Parternship Resource for Investigating Human Diseases and Training (SPRINT)

Modeling and understanding alveolar hypoplasia in Down syndrome using iPSCs-derived alveolar type II cells

  • Post author:
  • Post category:

Research Objective Understanding alveolar progenitor cell defects in T21 and the genes/pathways associated with them will allow for developing therapeutic approaches for individuals with DS. Impact Although trisomy 21 affects…

Continue ReadingModeling and understanding alveolar hypoplasia in Down syndrome using iPSCs-derived alveolar type II cells

An interactive data resource for hypothesis testing in stem cell single-cell gene expression and validation of the results with brain organoids

  • Post author:
  • Post category:

Research Objective We are building a "virtual molecular microscope" where anyone can quickly visualize a very recent, high-throughput molecular assay, single-cell RNA-seq and spatial gene expression studies Impact Currently, a…

Continue ReadingAn interactive data resource for hypothesis testing in stem cell single-cell gene expression and validation of the results with brain organoids

Development of a stem-cell based approach to interpret global effects of genetic variants contributing to neurodevelopmental disease risk

  • Post author:
  • Post category:

Research Objective We are developing a strategy to characterize the disease-relevance of hundreds of mutations across diverse genetic backgrounds using stem cells Impact Understanding how mutations impact cellular function can…

Continue ReadingDevelopment of a stem-cell based approach to interpret global effects of genetic variants contributing to neurodevelopmental disease risk